Nexalin Technology, Inc. (NXL)
0.8317
+0.03
(+3.29%)
USD |
NASDAQ |
Dec 19, 16:00
0.8193
-0.01
(-1.49%)
After-Hours: 20:00
Nexalin Technology EPS Diluted (Quarterly): -0.1279 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Standard BioTools, Inc. | -0.0906 |
| LENSAR, Inc. | -0.3083 |
| Intelligent Bio Solutions, Inc. | -0.349 |
| Adagio Medical Holdings, Inc. | -0.6578 |
| Movano, Inc. | -4.734 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.276M |
| Revenue (Quarterly) | 0.0181M |
| Total Expenses (Quarterly) | 2.294M |
| Enterprise Value | 11.16M |
| Gross Profit Margin (Quarterly) | -2.41K% |
| Profit Margin (Quarterly) | -12.58K% |
| Earnings Yield | -71.05% |
| Normalized Earnings Yield | -71.05 |